CHMP Backs Bone Drug Restrictions, EU Bans Tetrazepam Medicines

Acting on fresh health-risk assessments, the European Medicines Agency’s pharmacovigilance panel is calling for an EU-wide suspension of tetrazepam-containing drugs and recommending new restrictions on the use of a pair of French-made osteoporosis drugs.
International Pharmaceutical Regulatory Monitor